36
Views
0
CrossRef citations to date
0
Altmetric
Review

Managing Late-Life Bipolar Disorder: An Update

, , &
Pages 557-571 | Published online: 12 Aug 2011

Bibliography

  • Kessler RC , BerglundP, DemlerO et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch. Gen. Psychiatry 62(6) , 593–602 (2005).
  • Weissman MM , BlandRC, CaninoGJ et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276(4) , 293–299 (1996).
  • Kessler RC , McGonagleKA, ZhaoS et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch. Gen. Psychiatry 51(1) , 8–19 (1994).
  • Regier DA , BoydJH, BurkeJD Jr et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch. Gen. Psychiatry45(11) , 977–986 (1988).
  • Judd LL , AkiskalHS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord.73(1–2) , 123–131 (2003).
  • Akiskal HS , BourgeoisML, AngstJ et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 59(Suppl. 1) , S5–S30 (2000).
  • Szadoczky E , PappZ, VitraiJ et al. The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. J. Affect. Disord. 50(2–3) , 153–162 (1998).
  • Chen P , AhmedM, SajatovicM. Bipolar disorder in later life. Aging Health2(2) , 333–347 (2006).
  • Weissman MM , LeafPJ, TischlerGL et al. Affective disorders in five United States communities. Psychol. Med. 18(1) , 141–153 (1988).
  • Unutzer J , SimonG, PabiniakC et al. The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatr. Serv. 49(8) , 1072–1078 (1998).
  • Hirschfeld RM , CalabreseJR, WeissmanMM et al. Screening for bipolar disorder in the community. J. Clin. Psychiatry 64(1) , 53–59 (2003).
  • Almeida OP , FennerS. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int. Psychogeriatr.14(3) , 311–322 (2002).
  • Yassa R , NairV, NastaseC et al. Prevalence of bipolar disorder in a psychogeriatric population. J. Affect. Disord. 14(3) , 197–201 (1988).
  • Depp CA , LindamerLA, FolsomDP et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am. J. Geriatr. Psychiatry 13(4) , 290–298 (2005).
  • Depp CA , JesteDV. Bipolar disorder in older adults: a critical review. Bipolar Disord.6(5) , 343–367 (2004).
  • Morgan VA , MitchellPB, JablenskyAV. The epidemiology of bipolar disorder: sociodemographic, disability and service utilization data from the Australian national study of low prevalence (psychotic) disorders. Bipolar Disord.7(4) , 326–337 (2005).
  • Meeks S . Bipolar disorder in the latter half of life: symptom presentation, global functioning and age of onset. J. Affect. Disord.52(1–3) , 161–167 (1999).
  • Sajatovic M , BlowFC, IgnacioRV et al. New-onset bipolar disorder in later life. Am. J. Geriatr. Psychiatry 13(4) , 282–289 (2005).
  • Vasudev A , ThomasA. ‘Bipolar disorder‘ in the elderly: what‘s in a name? Maturitas66(3) , 231–235 (2010).
  • Kessing LV . Diagnostic subtypes of bipolar disorder in older versus younger adults. Bipolar Disord.8(1) , 56–64 (2006).
  • Lehmann SW , RabinsPV. Factors related to hospitalization in elderly manic patients with early and late onset bipolar disorder. Int. J. Geriatr. Psychiatry21(11) , 1060–1064 (2006).
  • Goldstein BI , HerrmannN, ShulmanKI. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am. J. Psychiatry163(2) , 319–321 (2006).
  • Beyer JL , KuchibhatlaM, CassidyF et al. Stressful life events in older bipolar patients. Int. J. Geriatr. Psychiatry 23(12) , 1271–1275 (2008).
  • Radanovic M , NunesPV, GattazWF et al. Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int. Psychogeriatr. 20(4) , 687–696 (2008).
  • Gildengers AG , MulsantBH, BegleyA et al. The longitudinal course of cognition in older adults with bipolar disorder. Bipolar Disord. 11(7) , 744–752 (2009).
  • Gunning-Dixon FM , MurphyCF, AlexopoulosGS et al. Executive dysfunction in elderly bipolar manic patients. Am. J. Geriatr. Psychiatry 16(6) , 506–512 (2008).
  • Prakash O , KumarCN, ShivakumarPT et al. Clinical presentation of mania compared with depression: data from a geriatric clinic in India. Int. Psychogeriatr. 21(4) , 764–767 (2009).
  • Depp CA , MooreDJ, SitzerD et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J. Affect. Disord. 101(1–3) , 201–209 (2007).
  • Schouws SN , ZoetemanJB, ComijsHC et al. Cognitive functioning in elderly patients with early onset bipolar disorder. Int. J. Geriatr. Psychiatry 22(9) , 856–861 (2007).
  • Gildengers AG , ButtersMA, ChisholmD et al. Cognitive functioning and instrumental activities of daily living in late-life bipolar disorder. Am. J. Geriatr. Psychiatry 15(2) , 174–179 (2007).
  • Delaloye C , MoyG, BaudoisS et al. Cognitive features in euthymic bipolar patients in old age. Bipolar Disord. 11(7) , 735–743 (2009).
  • Tsai SY , LeeHC, ChenCC et al. Cognitive impairment in later life in patients with early-onset bipolar disorder. Bipolar Disord. 9(8) , 868–875 (2007).
  • Tsai SY , KuoCJ, ChungKH et al. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. Am. J. Geriatr. Psychiatry 17(12) , 1004–1011 (2009).
  • Subramaniam H , DennisMS, ByrneEJ. The role of vascular risk factors in late onset bipolar disorder. Int. J. Geriatr. Psychiatry22(8) , 733–737 (2007).
  • Krauthammer C , KlermanGL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch. Gen. Psychiatry35(11) , 1333–1339 (1978).
  • Van Gerpen MW , JohnsonJE, WinsteadDK. Mania in the geriatric patient population: a review of the literature. Am. J. Geriatr. Psychiatry7(3) , 188–202 (1999).
  • Ganzini L , MillarSB, WalshJR. Drug-induced mania in the elderly. Drugs Aging3(5) , 428–435 (1993).
  • Abouesh A , StoneC, HobbsWR. Antimicrobial-induced mania (antibiomania): a review of spontaneous reports. J. Clin. Psychopharmacol.22(1) , 71–81 (2002).
  • Robinson RG . Mood disorders secondary to stroke. Semin. Clin. Neuropsychiatry2(4) , 244–251 (1997).
  • Nakimuli-Mpungu E , MusisiS, Kiwuwa Mpungu S et al. Early-onset versus late onset HIV-related secondary mania in Uganda. Psychosomatics49(6) , 530–534 (2008).
  • Owe-Larsson B , SallL, SalamonE et al. HIV infection and psychiatric illness. Afr. J. Psychiatry (Johannesbg) 12(2) , 115–128 (2009).
  • Sajatovic M . Treatment of bipolar disorder in older adults. Int. J. Geriatr. Psychiatry17(9) , 865–873 (2002).
  • Catterson ML , PreskornSH, MartinRL. Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatr. Clin. N. Am.20(1) , 205–218 (1997).
  • Sunderland T . Neurotransmission in the aging central nervous system. In: Clinical geriatric Psychopharmacology. Salzman C (Ed.). Lippincott Williams & Wilkins, PA, USA, 63–86 (2005).
  • Bowden CL , BruggerAM, SwannAC et al. Efficacy of divalproex lithium and placebo in the treatment of mania. The depakote mania study group. JAMA 271(12) , 918–924 (1994).
  • Bowden CL , MosolovS, HranovL et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Int. Clin. Psychopharmacol. 25(2) , 60–67 (2010).
  • BALANCE Investigators and Collaborators; Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet375(9712) , 385–395 (2010).
  • Kessing LV , SondergardL, KvistK et al. Suicide risk in patients treated with lithium. Arch. Gen. Psychiatry 62(8) , 860–866 (2005).
  • Schaffer CB , GarveyMJ. Use of lithium in acutely manic elderly patients. Clin. Gerontol.3 , 58–60 (1984).
  • Shulman KI , RochonP, SykoraK et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 326(7396) , 960–961 (2003).
  • Blanco C , LajeG, OlfsonM et al. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 159(6) , 1005–1010 (2002).
  • Young RC , SchulbergHC, GildengersAG et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord. 12(1) , 56–67 (2010).
  • Forester BP , StreeterCC, BerlowYA et al. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am. J. Geriatr. Psychiatry 17(1) , 13–23 (2009).
  • Juurlink DN , MamdaniMM, KoppA et al. Drug-induced lithium toxicity in the elderly: a population-based study. J. Am. Geriatr. Soc. 52(5) , 794–798 (2004).
  • Shulman KI , SykoraK, GillSS et al. New thyroxine treatment in older adults beginning lithium therapy: implications for clinical practice. Am. J. Geriatr. Psychiatry 13(4) , 299–304 (2005).
  • Vestergaard P , RejnmarkL, MosekildeL. Reduced relative risk of fractures among users of lithium. Calcif. Tissue Int.77(1) , 1–8 (2005).
  • Gildengers AG , MulsantBH, BegleyAE et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am. J. Geriatr. Psychiatry 13(4) , 319–323 (2005).
  • Allen MH , HirschfeldRM, WozniakPJ et al. Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania. Am. J. Psychiatry 163(2) , 272–275 (2006).
  • Chen ST , AltshulerLL, MelnykKA et al. Efficacy of lithium. Valproate in the treatment of mania in the elderly: a retrospective study. J. Clin. Psychiatry 60(3) , 181–186 (1999).
  • Sandson NB , MarcucciC, BourkeDL et al. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug–drug interactions. Am. J. Psychiatry 163(11) , 1891–1896 (2006).
  • Bowden CL , LawsonDM, CunninghamM. The role of divalproex in the treatment of bipolar disorder. Psychiatry Ann.32(12) , 742–750 (2002).
  • Post RM , UhdeTW, Roy-ByrnePP et al. Correlates of antimanic response to carbamazepine. Psychiatry Res. 21(1) , 71–83 (1987).
  • Evans DL , ByerlyMJ, GreerRA. Secondary mania: diagnosis and treatment. J. Clin. Psychiatry56(Suppl. 3) , 31–37 (1995).
  • Battino D , CrociD, RossiniA et al. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44(7) , 923–929 (2003).
  • Chen PJ . The efficacy and blood concentration monitoring of carbamazepine on mania. Zhonghua Shen Jing Jing Shen Ke Za Zhi23(5) , 261–265, 318 (1990).
  • Leppik IE . Issues in the treatment of epilepsy. Epilepsia.42(Suppl. 4) , 1–6 (2001).
  • Fuller M , SajatovicM. Drug Information Handbook for Psychiatry Lexi-Comp, Inc., Cleveland, OH, USA (2009).
  • Calabrese JR , BowdenCL, SachsG et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry 64(9) , 1013–1024 (2003).
  • Bowden CL , CalabreseJR, SachsG et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry 60(4) , 392–400 (2003).
  • Sajatovic M , GyulaiL, CalabreseJR et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am. J. Geriatr. Psychiatry 13(4) , 305–311 (2005).
  • Sajatovic M , GildengersA, Al Jurdi RK et al. Multi-site, open-label, prospective trial of lamotrigine for geriatric bipolar depression (2010). Presented at: The American Psychiatric Association Conference. New Orleans, LA, USA, 14–16 May 2010.
  • Willmore LJ , MessenheimerJA. Adult experience with lamotrigine. J. Child Neurol.12(Suppl. 1) , S16–S18 (1997).
  • Messenheimer JA . Lamotrigine. Epilepsia.36(Suppl. 3) , S87–S94 (1995).
  • Beyer JL , SiegalA, KennedyJS. Olanzapine, divalproex and placebo treatment, non-head to head comparisons of older adults acute mania. Presented at: 10th Congress of the International Psychogeriatric Association. Nice, France, 9–14 September 2001.
  • Sajatovic M , CoconceaN, IgnacioRV et al. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J. Clin. Psychiatry 69(1) , 41–46 (2008).
  • Sajatovic M . Quetiapine for the treatment of depressive episodes in adults aged 55 to 65 years with bipolar disorder. Presented at: American Association of Geriatric Psychiatry (AAGP) Annual Meeting. New Orleans, LA, USA, 1–4 March 2007.
  • Madhusoodanan S , BrennerR, AraujoL et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J. Clin. Psychiatry 56(11) , 514–518 (1995).
  • Madhusoodanan S , SureshP, BrennerR et al. Experience with the atypical antipsychotics – risperidone and olanzapine in the elderly. Ann. Clin. Psychiatry 11(3) , 113–118 (1999).
  • Shulman RW , SinghA, ShulmanKI. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol. Bull.33(1) , 113–118 (1997).
  • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care27(2) , 596–601 (2004).
  • Wang PS , SchneeweissS, AvornJ et al. Risk of death in elderly users of conventional atypical antipsychotic medications. N. Engl. J. Med. 353(22) , 2335–2341 (2005).
  • Kales HC , ValensteinM, KimHM et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am. J. Psychiatry 164(10) , 1568–1576 (2007).
  • Aziz R , LorbergB, TampiRR. Treatments for late-life bipolar disorder. Am. J. Geriatr. Pharmacother.4(4) , 347–364 (2006).
  • Crystal S , OlfsonM, HuangC et al. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff. (Millwood) 28(5) , W770–W781 (2009).
  • Sachs GS , NierenbergAA, CalabreseJR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N. Engl J. Med. 356(17) , 1711–1722 (2007).
  • Goldberg JF , PerlisRH, GhaemiSN et al. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am. J. Psychiatry 164(9) , 1348–1355 (2007).
  • Schaffer A , MamdaniM, LevittA et al. Effect of antidepressant use on admissions to hospital among elderly bipolar patients. Int. J. Geriatr. Psychiatry 21(3) , 275–280 (2006).
  • Aizenberg D , OlmerA, BarakY. Suicide attempts amongst elderly bipolar patients. J. Affect. Disord.91(1) , 91–94 (2006).
  • Leverich GS , AltshulerLL, FryeMA et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am. J. Psychiatry 163(2) , 232–239 (2006).
  • Duboky SL . Treatment of bipolar depression. Psychiatr. Clin. North Am.28(2) , 349–370 (2005).
  • Weiner RD , CoffeyCE, FochtmannLJ et al. The Practice of Electroconvulsive Therapy. Recommendations for the Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association Washington. American Psychiatric Association, Washington, DC, USA (2001).
  • Mukherjee S , SackeimHA, SchnurDB. Electroconvulsive therapy of acute manic episodes: a review of 50 years‘ experience. Am. J. Psychiatry151(2) , 169–176 (1994).
  • Ciapparelli A , Dell‘OssoL, TundoA et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J. Clin. Psychiatry 62(7) , 552–555 (2001).
  • Devanand DP , PolancoP, CruzR et al. The efficacy of ECT in mixed affective states. J. ECT 16(1) , 32–37 (2000).
  • Gruber NP , DilsaverSC, ShoaibAM et al. ECT in mixed affective states: a case series. J. ECT 16(2) , 183–188 (2000).
  • Medda P , PerugiG, ZanelloS et al. Response to ECT in bipolar I, bipolar II and unipolar depression. J. Affect. Disord. 118(1–3) , 55–59 (2009).
  • Daly JJ , PrudicJ, DevanandDP et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord. 3(2) , 95–104 (2001).
  • Grunhaus L , SchreiberS, DolbergOT et al. Response to ECT in major depression: are there differences between unipolar and bipolar depression? Bipolar Disord. 4(Suppl. 1) , 91–93 (2002).
  • Bailine S , FinkM, KnappR et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr. Scand. 121(6) , 431–436 (2010).
  • Hallam KT , SmithDI, BerkM. Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression. J. Affect. Disord.112(1–3) , 212–218 (2009).
  • Tew JD Jr, Mulsant BH, Haskett RF et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am. J. Psychiatry156(12) , 1865–1870 (1999).
  • O‘Connor MK , KnappR, HusainM et al. The influence of age on the response of major depression to electroconvulsive therapy: A C.O.R.E. Report. Am. J. Geriatric. Psychiatry 9 , 382–390 (2001).
  • Dombroki AY , MulsantBH, HaskettRF et al. Predictors of remission after electroconvulsive therapy in unipolar major depression. J. Clin. Psychiatry 66 , 1043–1049 (2005).
  • Damm J , EserD, SchuleC et al. Influence of age on effectiveness and tolerability of electroconvulsive therapy. J. ECT 26(4) , 282–288 (2010).
  • Manly DT , OakleySP Jr, Bloch RM. Electroconvulsive therapy in old-old patients. Am. J. Geriatr. Psychiatry8(3) , 232–236 (2000).
  • Sackeim HA , PrudicJ, FullerR et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 32(1) , 244–254 (2007).
  • Kujala I , RosenvingeB, BekkelundSI. Clinical outcome and adverse effects of electroconvulsive therapy in elderly psychiatric patients. J. Geriatr. Psychiatry Neurol.15(2) , 73–76 (2002).
  • Russell JC , RasmussenKG, O‘ConnorMK et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J. ECT 19(1) , 4–9 (2003).
  • Vaidya NA , MahableshwarkarAR, ShahidR. Continuation and maintenance ECT in treatment-resistant bipolar disorder. J. ECT19(1) , 10–16 (2003).
  • Hallett M . Transcranial magnetic stimulation and the human brain. Nature406(6792) , 147–150 (2000).
  • Hoogendam JM , RamakersGM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul.3(2) , 95–118 (2010).
  • Milev R , AbrahamG, HaseyG et al. Repetitive transcranial magnetic stimulation for treatment of medication-resistant depression in older adults: a case series. J. ECT 25(1) , 44–49 (2009).
  • Abraham G , MilevR, LazowskiL et al. Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial. Neuropsychiatr. Dis. Treat. 3(6) , 919–924 (2007).
  • Mosimann UP , SchmittW, GreenbergBD et al. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res. 126(2) , 123–133 (2004).
  • Manes F , JorgeR, MorcuendeM et al. A controlled study of repetitive transcranial magnetic stimulation as a treatment of depression in the elderly. Int. Psychogeriatr. 13(2) , 225–231 (2001).
  • Nahas Z , LiX, KozelFA et al. Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55–75 years of age: a pilot study. Depress. Anxiety 19(4) , 249–256 (2004).
  • Cohen RB , BrunoniAR, BoggioPS et al. Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: a naturalistic study. J. Nerv. Ment. Dis. 198(9) , 679–681 (2010).
  • Loo CK , MitchellPB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J. Affect. Disord.88(3) , 255–267 (2005).
  • Rachid F , BertschyG. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of depression: a critical appraisal of the last 10 years. Neurophysiol. Clin.36(3) , 157–183 (2006).
  • Xia G , GajwaniP, MuzinaDJ et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int. J. Neuropsychopharmacol. 11(1) , 119–130 (2008).
  • Moser DJ , JorgeRE, ManesF et al. Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 58(8) , 1288–1290 (2002).
  • Huang CC , WeiIH, ChouYH et al. Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology 33(6) , 821–831 (2008).
  • Hamani C , NobregaJN. Deep brain stimulation in clinical trials and animal models of depression. Eur. J. Neurosci.32(7) , 1109–1117 (2010).
  • Lipsman N , McIntyreRS, GiacobbeP et al. Neurosurgical treatment of bipolar depression: defining treatment resistance and identifying surgical targets. Bipolar Disord. 12(7) , 691–701 (2010).
  • Neiberg RH , AickinM, GrzywaczJG et al. Occurrence and co-occurrence of types of complementary and alternative medicine use by age, gender, ethnicity, and education among adults in the United States: the 2002 national health interview survey (NHIS). J. Altern. Complement Med. 17(4) , 363–370 (2011).
  • Keaton D , LamkinN, CassidyKA et al. Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression. Int. J. Geriatr. Psychiatry 24(10) , 1087–1093 (2009).
  • Miklowitz DJ , OttoMW, FrankE et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. Arch. Gen. Psychiatry 64(4) , 419–426 (2007).
  • Miklowitz DJ , OttoMW, WisniewskiSR et al. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder. Psychiatr. Serv. 57(7) , 959–965 (2006).
  • Frank E , SorecaI, SwartzHA et al. The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am. J. Psychiatry 165(12) , 1559–1565 (2008).
  • Clarkin JF , CarpenterD, HullJ et al. Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatr. Serv. 49(4) , 531–533 (1998).
  • Miklowitz DJ . Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am. J. Psychiatry165(11) , 1408–1419 (2008).
  • Antognini F : Psychotherapy with Depressed Older Adults. In: Depression in Later Life: A Multidisciplinary Psychiatric Approach. Ellison JM, Verma S (Eds.), Marcel Dekker, New York, NY, USA, 257–296 (2003).
  • Simon NM , SmollerJW, McNamaraKL et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 60(5) , 432–435 (2006).
  • Yatham LN , KapczinskiF, AndreazzaAC et al. Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int. J. Neuropsychopharmacol. 12(1) , 137–139 (2009).
  • Berk M . Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int. J. Neuropsychopharmacol.12(4) , 441–445 (2009).
  • Kapczinski F , VietaE, AndreazzaAC et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 32(4) , 675–692 (2008).
  • Kessing LV , AndersenPK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J. Neurol. Neurosurg. Psychiatry75(12) , 1662–1666 (2004).
  • Sajatovic M , BlowFC, KalesHC et al. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int. J. Geriatr. Psychiatry 22(10) , 992–998 (2007).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.